Rachel Davis, MD
Psychiatry
Locations
Practice Locations
CU Medicine Psychiatry - Obsessive Compulsive Disorder (OCD) Clinic
CU Anschutz Medical Campus
1890 N Revere Ct Anschutz Health Sciences Bldg, Suite 5040, Aurora, CO 80045303-724-4987
CU Medicine Psychiatry - Outpatient Clinic
Anschutz Health Sciences Building
1890 N Revere Ct Anschutz Health Sciences Bldg, Suite 4020, Aurora, CO 80045303-724-1000
CU Medicine Psychiatry - Transcranial Magnetic Stimulation (TMS) Clinic
CU Anschutz Medical Campus
1890 N Revere Ct Anschutz Health Sciences Bldg, Suite 5242, Aurora, CO 80045303-724-6252
Provider Expertise
Specialties
- Psychiatry ( 2010 )
Conditions & Treatments
-
Mental Health and Behavior
Anxiety, Attention Deficit Disorder with Hyperactivity, Bereavement, Bipolar Disorder, Depression, Eating Disorders, Obsessive-Compulsive Disorder, Panic Disorder, Phobias, Postpartum Depression, Post-Traumatic Stress Disorder, Seasonal Affective Disorder, Stress
-
Wellness and Prevention
-
Stress Management
Interests & Activities
Volunteer Activities
Past President, Colorado Psychiatric Society; Chair, Ethics Committee, Colorado Psychiatric Society
Education & Training
Medical Schools
MD, University of Colorado Denver School of Medicine (2005)
Undergraduate Schools
BA, University of Colorado - Boulder (CO) (2000)
Internships
University of Colorado (University Hospital) Program (2006)
Residency Program
University of Colorado (University Hospital) Program (2009)
Professional Memberships
Alpha Omega Alpha Medical Honor Society (AOA), Member
American Association for Emergency Psychiatry (AAEP), Member
American Psychiatric Association (APA), Distinguished Fellow
American Society for Stereotactic and Functional Neurosurgery (ASSFN), Member
Colorado Psychiatric Society (CPS), Past President
CU School of Medicine Center for NeuroScience, Member
Gold Humanism Honor Society, Member
International Obsessive Compulsive Disorder Foundation (IOCDF), Member
Research & Grants
Grants
Leveraging ethical dissension among capacity, beneficence, and justice in clinical trials of neurotherapeutics in the severely disabled: lessons from schizophrenia (mPI with Gault J and Saks E) (2019)